Search
for
Sort by
Research 301–330 of 1000+
- General Dermatology
- Lab Quality Management and Methodology
- Acne and Systemic Disease
- Brachioradial pruritus: Treatment with topical capsaicin
- Is acne a sign of androgen excess disorder or not?
- Challenges in the Diagnosis of Simple-Virilizing Congenital Adrenal Hyperplasia: A Case Report
- Hormonal Therapy for Acne
- Regulatory roles of androgens in cutaneous wound healing
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Essential syphilitic alopecia revisited
- Endocrinologic Aspects of Hidradenitis Suppurativa
- Clinical relevance of testosterone and dihydrotestosterone metabolism in women
- Acne severity and the Global Acne Grading System in polycystic ovary syndrome
- Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China
- Ethinylestradiol/Chlormadinone Acetate
- New onset alopecia and hirsutism in a postmenopausal women
- Need for liver evaluation in polycystic ovary syndrome
- Acne in hirsute women
- A Rare Case of Steroid Cell Tumor, Not Otherwise Specified (NOS), of the Ovary in a Young Woman
- The Case of the Elusive Androgen
- Efficacy and safety of systemic spironolactone for acne in female patients in Sulaymaniyah teaching center of dermatology
- Factors in the etiopathogenesis of post-adolescent female acne
- 46, XY Disorder of Sexual Development with Ambiguous Female External Genitalia: A Case Report
- Postmenopausal Alopecia due to Ovarian Hyperandrogenemia Treated with Bilateral Salpingo-oophorectomy
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
- Neuroactive Steroids and Ethanol Exposure: Relevance to Ethanol Sensitivity and Alcohol Use Disorders Risk
- Spironolactone
- Antiandrogen Treatment with Spironolactone and Linestrenol Decreases Bone Mineral Density in Eumenorrhoeic Women with Androgen Excess
- New Criteria for the Clinical Diagnosis of Hyperandrogenism in Polycystic Ovarian Syndrome and the Risk of Overdiagnosis
- Hormonal therapy for acne: why not as first line therapy? facts and controversies